The voluntary buyout offer is the clearest sign yet that Microsoft will trim headcount even as it accelerates AI infrastructure spending.

New rules require a year of maintenance, three contributors, and English fluency, leaving independent developers locked out of the forum they need to grow.

The AI safety pioneer's IPO filing calls 'closing the loop' the best route to triumph and a risk to humanity, a dual warning investors and boards should not skim past.

The Claude maker files publicly for a Nasdaq listing under 'ANT,' exposing staggering losses and a world-altering ambition before it can beat OpenAI to the market.

The suffix that conquered gaming, sleep, and the military is the word of the year - and it's a signal for how you brand, hire, and compete.

Microsoft is hunting a buyer or partner for the studio behind Marvel's Blade, with French labor law and a union fight shaping the outcome.

The AI startup sits atop a pyramid of partners and suppliers, so its public debut will ripple far beyond one stock.

The AI buildout is minting fortunes beyond GPUs, and memory, cloud, and cooling suppliers are riding the same wave.

Micro1 is paying midsize companies $100,000 to $2 million for their internal data, and CEOs are cashing in before the AI data boom matures.

From fast food to rideshare, hidden algorithms decide what you pay - and a consumer backlash is building.

CEO Minami Maeda is running Phase 3 trials and targeting a 2028 FDA submission as photoimmunotherapy moves from Japanese clinics toward the world's largest market.

A simple liquid painted on in seconds just cleared a major clinical trial, cutting the need for pediatric dental surgery and speeding the path to FDA approval.